A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

NCT04740931 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

729

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Edema
Central Retinal Vein Occlusion
Hemiretinal Vein Occlusion

Interventions

DRUG: Faricimab
DRUG: Aflibercept
PROCEDURE: Sham Procedure

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]